A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
Clinical trial NCT01920737 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01920737
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-07
- Primary completion
- 2026-08-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.